
7percent
Investor participating in BioOrbit's £9.8m seed round.
Last refreshed: 23 July 2026 · Appears in 1 active topic
What investment approach does 7percent Ventures use at seed stage?
Timeline for 7percent
Mentioned in: BioOrbit raises £9.8m for orbital pharma
UK Startups and InnovationBackground
7percent Ventures is a London-based early-stage venture capital investor that focuses on pre-seed and seed rounds, writing smaller cheques and participating alongside larger co-investors in high-conviction syndicates. The fund's name reflects its philosophy of taking a meaningful but non-controlling position in very early-stage companies, preserving founder ownership while securing a stake large enough to drive meaningful returns. It primarily backs technology-led founders in Europe.
7percent typically operates as a participant investor rather than a deal lead, co-investing with established seed funds and accelerators. Its portfolio is concentrated in B2B software, fintech and increasingly deep tech as the European seed landscape has shifted toward Science-led ventures.
7percent participated in BioOrbit's £9.8m in-space drug manufacturing seed in April 2026 as part of the syndicate alongside LocalGlobe, Breega, Auxxo, Seedcamp and Type One. The round is the world's largest seed for in-space manufacturing, enabled by a joint UK regulatory pathway published by four government bodies in March 2026.